Ostarine (Ostarol, GTx-024, MK-2866): A Widely Used Selective Androgen Receptor Modulator (SARM)
Ostarine is a selective androgen receptor modulator originally brought forward by Merck & Company and GTx Incorporated as a candidate therapy for osteoporosis and muscular dystrophy. A fairly recent arrival on the domestic market — and one that has caught on at some pace.
Across the US, SARMs have picked up a steady following amongst competitive athletes. Ostarine, in particular, tends to work its way into training and nutrition plans — especially during the run-up to a meet.
Effectiveness and Usage
The track record speaks for itself. One case stands out: a competitor who posted the season’s best result at the World Long Jump Championship was suspended after Ostarine turned up in testing. Not a result a mild compound tends to produce.












Reviews
There are no reviews yet